Integra LifeSciences Holdings (NASDAQ:IART) has acquired Rebound Therapeutics, developers of single-use medical devices that enable minimally invasive access for therapeutic use in neurosurgery.
Financial details are not disclosed.
Integra does not expect this acquisition to have a material financial impact in 2019.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.